Your browser doesn't support javascript.
loading
Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical Trials.
Holland, Edward J; Jackson, Mitchell A; Donnenfeld, Eric; Piccolo, Rebecca; Cohen, Alisa; Barabino, Stefano; Rolando, Maurizio; Figueiredo, Francisco C.
Afiliação
  • Holland EJ; Cincinnati Eye Institute, University of Cincinnati, Cincinnati, Ohio.
  • Jackson MA; Jacksoneye, Lake Villa, Illinois.
  • Donnenfeld E; New York University Medical Center, New York.
  • Piccolo R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Cohen A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Barabino S; Ocular Surface and Dry Eye Center, University of Milan, Milan, Italy.
  • Rolando M; Ocular Surface Centre, ISPRE (Instituto di Medicina Oftalmica) Ophthalmic, Genoa, Italy.
  • Figueiredo FC; Department of Ophthalmology, Royal Victoria Infirmary and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.
JAMA Ophthalmol ; 139(11): 1200-1208, 2021 Nov 01.
Article em En | MEDLINE | ID: mdl-34617974
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes do Olho Seco Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes do Olho Seco Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article